Clinical Trial Update: Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ertapenem sodium to piperacillin/tazobactam for diabetic foot infections in Chinese adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Infection

Drugs mentioned

• ERTAPENEM SODIUM (ertapenem sodium)
• Piperacillin/tazobactam (Piperacillin/tazobactam)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Infection; Diabetic Foot | Phase 3 | Status: COMPLETED | Results posted: 2014-12-02